The Orphan Drug Machine
KHN Video: Warrior Luke
Luke Whitbeck’s life was saved by a rare disease drug, but it costs $300,000 a year.
Search
Filter
8,021 - 8,040 of 15,300 Results
-
-
Laughing Until You Die
Humor may be an antidote for the pain of death for both patients and survivors.
-
Repeal & Replace Watch
A Guide To Budget Reconciliation: The Byzantine Rules For Disassembling The Health Law
Republicans, who don’t have the votes to repeal the ACA directly, are hoping to use this strict budget strategy that requires only a majority vote to strip the health law of provisions they oppose.
By Julie Rovner and Francis Ying -
Q&A: Efforts To Extend Health Coverage To Undocumented Immigrants
California state Sen. Ricardo Lara talks about progress and setbacks in the Trump era.
-
Judge Accepts Medicare’s Plan To Remedy Misunderstanding On Therapy Coverage
Many seniors are denied coverage because therapists mistakenly believe that they must be making improvements to qualify for coverage.
By Susan Jaffe -
Repeal & Replace Watch
Employers Fret Job-Based Coverage Vulnerable To Fallout From GOP Health Overhaul
Employer medical insurance still covers more people than any other kind. A Republican replacement for Obamacare could spread instability beyond the health law’s shaky marketplace plans.
By Jay Hancock -
Preserving Fertility When It Is Threatened By Life-Saving Medicine
A bill recently introduced in the California legislature would require insurance companies to cover fertility-preserving services for patients at risk of infertility because of necessary medical treatments.
By Anna Gorman -
Repeal & Replace Watch
HSAs: ‘Tax-Break Trifecta’ Or Insurance Gimmick Benefiting The Wealthy?
Republicans hope to expand the use of health savings accounts to encourage consumers to be more judicious in using their coverage. Here’s an explainer of how they work.
-
Trump’s Immigration Ban Fuels Fear For Young Doctors Whose Jobs May Be In Limbo
With announcements of placements in residencies expected in March, medical education groups and hospitals say they’re unsure how to proceed.
-
Women Fear Drug They Used To Halt Puberty Led To Health Problems
Despite questions about Lupron’s lasting side effects and minimal study into its safety, the FDA sped approval of the drug to market. Years later, some young women are still living with the consequences.
-
Repeal & Replace Watch
Indiana, Pence’s Home State, Seeks Federal OK To Keep Medicaid Expansion
Indiana asked the Trump administration Tuesday to renew funding for its Medicaid expansion under the health law, which is due to expire in January 2018.
-
Repeal & Replace Watch
Democrats Say Cabinet Choice Tom Price ‘Misled’ The Public. Here’s What We Know.
Concerns over U.S. Rep. Tom Price’s answers about stock trades led Senate Democrats to boycott a committee vote that would have moved his nomination to the Senate floor.
-
Repeal & Replace Watch
Hospitals Worry Repeal Of Obamacare Would Jeopardize Innovations In Care
One part of the federal health law gave hospitals financial incentives to improve patient care. Some invested big to make those changes and are worried about what losing that support would mean.
-
Renewed Cleaning Efforts For Scopes Not Enough To Vanquish Bacteria
A new study, though small, finds extensive damage to commonly used medical scopes that could trap dangerous bacteria. That raises concerns about the potential for more outbreaks.
By Chad Terhune -
Prescribing Opioids To Seniors: It’s A Balancing Act
An expert geriatrician says the benefits for the patient, such as alleviating pain and maintaining independence, must be weighed against the possible risks. Her motto: ‘start low and go slow.’
By Jenny Gold -
Repeal & Replace Watch
Demand For Popular Short-Term Insurance Plans Could Surge If Health Law Is Relaxed
Consumer advocates warn that these policies don’t have important safeguards that customers need.
-
Medicare’s Coverage Of Therapy Services Again Is In Center Of Court Dispute
According to a settlement four years ago, Medicare was supposed to make clear to therapists that their services are covered even if beneficiaries are not improving. But that is not yet widely accepted.
By Susan Jaffe -
Trying To Solve The Alzheimer’s Puzzle
Alzheimer's researchers hold onto hope after another promising trial ends in disappointment.
-
Drug Prices, Opioids, And Obamacare: A Conversation With Assemblyman Jim Wood
Wood, who chairs the Assembly Health Committee, lays out his priorities for 2017.
-
Getting Patients Hooked On An Opioid Overdose Antidote, Then Raising The Price
The device, known as Evzio, administers just enough naloxone to stabilize someone who has overdosed on drugs. But its manufacturer, Kaleo, may be positioning itself to find profits in a dire health care crisis.